HANXBIO-B
0337818AListed醫療健康 · 翰思生物（武汉）股份有限公司是一家专注于生物制药研发的中国公司，本次全球发售18,321,000股H股，最高发售价为每股32.00港元。
Cautious
61.7
/100
- Offer price
- HK$32.00
- Final offer price
- HK$32.00
- Lot / entry fee
- 100 shares · HK$3K
- Proceeds
- HK$586.3M
- Sponsor
- ICBC International
- Est. margin oversub.
- 2595.5x
- Public oversub.
- 3074.1x
- One-lot win rate
- 1.0%
- First-day return
- -46.3%
Offer starts
Dec 15
Offer closes
Dec 18
Grey market
Dec 22
Listing
Dec 23
AI reference scoring and scenarios
After grey market
After grey market L1 heat score
61.7/ 100
Data coverage High
Target
Historical calibration
Listing-day trend
Neutral-negativePartial basis
Up probability
52.0%
First-day reference range
-47.9% – +2.1%
Published outcome check
First-day resultBig down-46.3%
Our call: Trend call valid
Covered 14/25 core factors
UsedMissingNot yet scorableN/A
Margin oversubscription
High heatOffer size
Good qualityCornerstone lockup
—Post-lockup offer value
—Recent same-rule trend
Poor trendRecent same-type trend
Strong trendRecent sector trend
Strong trendValuation
Average appealFundamental quality
Average qualityGrowth quality
—Profitability
Weak qualityCash runway
Average qualityCustomer concentration
—Cornerstone quality
—Sponsor record
—Greenshoe arrangementGreenshoe: yes · 15%
Average supportStabilizer track record
—A-share pre-grey trend
—A-share listing-day trend
—Public oversubscription
High heatOne-lot win rate
High heatInternational placing
High heatFinal pricing position
—Actual greenshoe use
—Grey market return
Poor trendThe assessment and probability ranges are informational only and are not investment advice.
AI Research Report
After grey marketThe analysis report for this IPO is being generated.